When the macrophages’ ability to consume dying cancer cells or Upd3 production was decreased, tumor growth was significantly ...

Detalimogene voraplasmid gains FDA RMAT designation, showcasing a 71% response rate in treating high-risk, BCG-unresponsive ...

I Hummingbird Bioscience, a biotherapeutics company discovering and developing transformative medicines for hard-to-treat diseases, ...

Acanthosis Nigricans (AN) is more than just a skin condition, it's a symptom of possible internal health conditions. Quickly ...

Volume 32 of SLAS Technology, includes one review, one tech brief, six original research articles, one protocol, one literature ...

On Friday, June 13, 2025, the Middle East hovered on the brink of a conflagration unlike any seen before.Israel’s Operation Rising Lion unleashed over two hundred fighter jets in a blistering assault ...